CHMP2B and frontotemporal dementia: In support of this, a study found that patients with CHMP2B-FTD showed an increase in cerebral blood flow at the initial phase of the disease (Gydesen et al., 1987), which may be a sign of a compensatory upregulation and possibly associated with functional changes as measured with EEG.